Stevan R. Hubbard

Stevan R. Hubbard

New York University

H-index: 63

North America-United States

About Stevan R. Hubbard

Stevan R. Hubbard, With an exceptional h-index of 63 and a recent h-index of 34 (since 2020), a distinguished researcher at New York University, specializes in the field of Insulin and IGF1 receptor signaling, MuSK signaling, JAK2 signaling, tyrosine kinase inhibitors.

His recent articles reflect a diverse array of research interests and contributions to the field:

Biochemical characterization of the Drosophila insulin receptor kinase and longevity‐associated mutants

Identification of novel small molecule ligands for JAK2 pseudokinase domain

New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation

Structural basis of Janus kinase trans-activation

Unlocking the secrets to Janus kinase activation

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations

Stevan R. Hubbard Information

University

Position

NYU School of Medicine

Citations(all)

23126

Citations(since 2020)

4893

Cited By

19786

hIndex(all)

63

hIndex(since 2020)

34

i10Index(all)

88

i10Index(since 2020)

67

Email

University Profile Page

New York University

Google Scholar

View Google Scholar Profile

Stevan R. Hubbard Skills & Research Interests

Insulin and IGF1 receptor signaling

MuSK signaling

JAK2 signaling

tyrosine kinase inhibitors

Top articles of Stevan R. Hubbard

Title

Journal

Author(s)

Publication Date

Biochemical characterization of the Drosophila insulin receptor kinase and longevity‐associated mutants

The FASEB Journal

Harini Krishnan

Sultan Ahmed

Stevan R Hubbard

W Todd Miller

2024/1/15

Identification of novel small molecule ligands for JAK2 pseudokinase domain

Pharmaceuticals

Anniina T Virtanen

Teemu Haikarainen

Parthasarathy Sampathkumar

Maaria Palmroth

Sanna Liukkonen

...

2023/1/4

New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation

Cell chemical biology

Matthew L Arwood

Yao Liu

Shannon K Harkins

David M Weinstock

Lei Yang

...

2023/6/15

Structural basis of Janus kinase trans-activation

Cell reports

Nathanael A Caveney

Robert A Saxton

Deepa Waghray

Caleb R Glassman

Naotaka Tsutsumi

...

2023/3/28

Unlocking the secrets to Janus kinase activation

Science

Ross L Levine

Stevan R Hubbard

2022/4/8

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

EBioMedicine

Takuya Tada

Hao Zhou

Belinda M Dcosta

Marie I Samanovic

Vidya Chivukula

...

2022/4/1

Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations

Science

Stephan Wilmes

Maximillian Hafer

Joni Vuorio

Julie A Tucker

Hauke Winkelmann

...

2020/2/7

See List of Professors in Stevan R. Hubbard University(New York University)